CERVICAL CANCER SCREENING WITH PAP SMEAR METHOD AND IVA TEST AT DERWATI PRATAMA CLINIC BANDUNG ON JULY 4, 2024
Olivia Angelina Layandro Angelina Layandro
Paper Contents
Abstract
Cervical cancer is the second most common cancer case, with 36,633 cases or 9.2% of the total cancer cases in Indonesia. Cervical cancer screening through IVA test and Pap smear in Indonesia have only covered 9.3% of women in the target population, which shows how important cervical cancer screening testing is in various regions in Indonesia. This study discusses the results of cervical cancer screening through Pap smear and IVA test conducted at the Derwati Pratama Clinic, Bandung on July 4, 2024. The results of the study showed a microcrystalline cellulose yield of 56.103%. The results of cervical cancer screening in 30 female participants aged 20-70 years from the area around Derwati, Rancasari District, Bandung showed that no patients were positive for intraepithelial lesions and malignancies.
Copyright
Copyright © 2025 Olivia Angelina Layandro. This is an open access article distributed under the Creative Commons Attribution License.